• In accordance with HIPAA regulations, patient confidentiality must be protected. Names, dates of scans, birth dates, ages, medical record numbers, zip codes and identities must not be included in the abstract or on images and graphs.
• The maximum character limit of the abstract is 2,200 including spaces; spaces do count towards the character limit. Use simple fonts.
• Italics, underline, bold, superscript and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables and graphs are accepted in the body of the abstract only. Do not use these in the title of the abstract.
•  The abstract may contain one small image and one graph. A minimum resolution of 500 dpi and format of tiff, jpg, or .eps is required.
  
• You may type or copy and paste the text of your abstract from a word processing document or a clipboard directly into the online abstract box.
  
• All required fields must be complete, or the submission will be marked incomplete. Abstract submissions with an “incomplete” status cannot be processed.
  
• Do not send multiple submissions of the same abstract. Duplicate abstracts will be rejected. Be sure to combine all the new information into one abstract.
  
• Always keep an original copy of your submitted abstract.
  
• Always proofread your abstract. Accepted abstracts will be published exactly as submitted.
  
• E-posters must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. ACR reserves the right to replace proprietary names with generic names.
  
• Institution names should not be included in the title or body of the abstract to keep the review process blind, fair and objective. Alternative language that may be used is "at an institution", or "A multi-institution" study, etc. This does not apply to cooperative research group names such as RTOG, SWOG, ECOG, etc.

AVOCACY, ECONOMICS AND HEALTH POLICY

Advocacy abstracts should pertain to federal and state issues that relate to imaging issues. These abstracts are NOT intended to target patient-related advocacy efforts regarding patient rights protection.

Economics and Health Policy abstracts focus on areas for radiology and radiation oncology services related to coverage of services, reporting/coding and reimbursement for new, revised, and existing services, policy and payment issues related to third party payers, tracking Medicaid managed care organizations, and new payment models.

INFORMATICS AND DATA SCIENCE

Should pertain to one or more of the following areas:

• Artificial intelligence (AI)
  
• Electronic medical records (EMRs)
  
• PACS
  
• Interoperability
  
• CAD
  
• Speech-recognition software
  
• Enterprise imaging
  
• Radiology business analytics
  
• Social media

LEADERSHIP AND PRACTICE MANAGEMENT

May target any of the following areas:

• Strategic initiatives that leaders can use to transition to value-based care.
  
• Operational metrics and processes for optimizing organizational effectiveness.
  
• Economic drivers catalyzing changes in healthcare practice.
  
• Negotiation principles and applications.
  
• Leadership development.
  
• Developing a culture of quality and safety.
  
• Medicolegal/ethical dilemmas.

QUALITY AND SAFETY 

Should pertain to one or more of the following areas:

• Patient safety (including radiation dose optimization).
• MRI safety.
• Contrast media use.
• Diagnostic or breast imaging accreditation and centers of excellence programs.
• Implementation of evidence-based radiology guidelines, practice parameters, technical standards, ACR Appropriateness Criteria® or Appropriate Use Criteria.
• Quality management in radiology practice (including quality improvement tools and methods such as use of data registries and structured reporting).
• Building a quality infrastructure.

TRAINING AND EDUCATION

Training and Education abstracts should introduce aspects of education theory that improve the way we educate trainees and colleagues. Abstracts focused on clinical radiology (i.e., more traditional abstracts seen at other national radiology meetings) will not be considered for this meeting.